(Total Views: 91)
Posted On: 03/30/2023 9:56:08 AM
Post# of 85297
$VTGN News Article - FDA Provides Positive Feedback to Vistagen Regarding Use of the Liebowitz Social Anxiety Scale (LSAS) as an Endpoint in Phase 3 Development of Fasedienol (PH94B) for Treatment of Social Anxiety Disorder https://marketwirenews.com/news-releases/fda-...24198.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
